• New Developments in the Understanding of Epilepsy and the Application of Antiepileptic Therapies
  • Brown Bag Consult: I'm Not Feeling Well
  • Pharmacy Sues DEA for Seizing Its Drugs
  • Confronting the Challenge of Health Care–Associated Infections
  • Checking Long-Term Care Blister Packs and Bingo Cards
  • Can You Read These Rxs? (November 2014)

Breaking News

Compounding Pharmacists Awaiting Trial Under Home Confinement
A pharmacist and a co-founder of the New England Compounding Center, which is in hot water for a deadly fungal meningitis outbreak that occurred in 2012, have been ordered to home confinement and GPS monitoring.
A phase 3 study showed that Pfizer’s pregabalin controlled-release formulation holds promise in adult patients with postherpetic neuralgia, the manufacturer announced in a press release.
New treatments that may slow the progression of Alzheimer's dementia are currently being examined.
The FDA today approved peramivir injection, an IV neuraminidase inhibitor intended to treat acute uncomplicated influenza in patients 18 or older who have been symptomatic for no more than 2 days.
Representatives proposed legislation that would require generic drug manufactures to pay a rebate to Medicaid if product prices rise at a rate greater than inflation.
A Tampa-based pharmacist could face a maximum of 20 years in federal prison after a jury found him guilty of conspiracy to distribute and dispense oxycodone.
Lundbeck will cease further development of its experimental desmoteplase compound for ischemic stroke.

From the Issue

Previous TabNext Tab
Strategic Alliance Partners
Latest Issues
$auto_registration$